nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—PLA2G4A—Epirubicin—peripheral nervous system neoplasm	0.659	1	CbGbCtD
Fluocinolone Acetonide—Triamcinolone—BCHE—peripheral nervous system neoplasm	0.000676	0.347	CrCbGaD
Fluocinolone Acetonide—Fluticasone furoate—ABCB1—peripheral nervous system neoplasm	0.000394	0.202	CrCbGaD
Fluocinolone Acetonide—Infection—Topotecan—peripheral nervous system neoplasm	0.000389	0.00114	CcSEcCtD
Fluocinolone Acetonide—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.000388	0.00114	CcSEcCtD
Fluocinolone Acetonide—Oedema—Tretinoin—peripheral nervous system neoplasm	0.000388	0.00114	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Alitretinoin—peripheral nervous system neoplasm	0.000387	0.00114	CcSEcCtD
Fluocinolone Acetonide—Infection—Tretinoin—peripheral nervous system neoplasm	0.000385	0.00114	CcSEcCtD
Fluocinolone Acetonide—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000385	0.00114	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000384	0.00113	CcSEcCtD
Fluocinolone Acetonide—Oedema—Melphalan—peripheral nervous system neoplasm	0.000383	0.00113	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00038	0.00112	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00038	0.00112	CcSEcCtD
Fluocinolone Acetonide—Infection—Melphalan—peripheral nervous system neoplasm	0.00038	0.00112	CcSEcCtD
Fluocinolone Acetonide—Viral infection—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.00109	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.000366	0.00108	CcSEcCtD
Fluocinolone Acetonide—Neck pain—Epirubicin—peripheral nervous system neoplasm	0.000365	0.00108	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.000363	0.00107	CcSEcCtD
Fluocinolone Acetonide—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.00107	CcSEcCtD
Fluocinolone Acetonide—Herpes simplex—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.00107	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.00036	0.00106	CcSEcCtD
Fluocinolone Acetonide—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00036	0.00106	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.00036	0.00106	CcSEcCtD
Fluocinolone Acetonide—Infestation—Etoposide—peripheral nervous system neoplasm	0.00036	0.00106	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.000359	0.00106	CcSEcCtD
Fluocinolone Acetonide—Dermatitis contact—Epirubicin—peripheral nervous system neoplasm	0.000356	0.00105	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.000356	0.00105	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.000353	0.00104	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.000353	0.00104	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Vincristine—peripheral nervous system neoplasm	0.000352	0.00104	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.000349	0.00103	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.000349	0.00103	CcSEcCtD
Fluocinolone Acetonide—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.000349	0.00103	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.000347	0.00102	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.00034	0.001	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00034	0.001	CcSEcCtD
Fluocinolone Acetonide—Neck pain—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000995	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000338	0.000995	CcSEcCtD
Fluocinolone Acetonide—Back pain—Vincristine—peripheral nervous system neoplasm	0.000336	0.000989	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000335	0.000987	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000335	0.000987	CcSEcCtD
Fluocinolone Acetonide—Pain—Topotecan—peripheral nervous system neoplasm	0.000334	0.000985	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Epirubicin—peripheral nervous system neoplasm	0.000333	0.000981	CcSEcCtD
Fluocinolone Acetonide—Pain—Tretinoin—peripheral nervous system neoplasm	0.000332	0.000977	CcSEcCtD
Fluocinolone Acetonide—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000332	0.000977	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000331	0.000974	CcSEcCtD
Fluocinolone Acetonide—Dermatitis contact—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000971	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.00033	0.000971	CcSEcCtD
Fluocinolone Acetonide—Pain—Melphalan—peripheral nervous system neoplasm	0.000327	0.000965	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000318	0.000936	CcSEcCtD
Fluocinolone Acetonide—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000317	0.000934	CcSEcCtD
Fluocinolone Acetonide—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000315	0.000928	CcSEcCtD
Fluocinolone Acetonide—Cough—Alitretinoin—peripheral nervous system neoplasm	0.000314	0.000926	CcSEcCtD
Fluocinolone Acetonide—Methylprednisolone—ABCB1—peripheral nervous system neoplasm	0.000314	0.161	CrCbGaD
Fluocinolone Acetonide—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000312	0.000919	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000312	0.000918	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000309	0.000911	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000908	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000307	0.000904	CcSEcCtD
Fluocinolone Acetonide—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000307	0.000904	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000307	0.000903	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000307	0.000903	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000307	0.000903	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000302	0.000889	CcSEcCtD
Fluocinolone Acetonide—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000294	0.000866	CcSEcCtD
Fluocinolone Acetonide—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.00086	CcSEcCtD
Fluocinolone Acetonide—Eczema—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000858	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000291	0.000858	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.00029	0.000854	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000289	0.000852	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000289	0.000851	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000288	0.000849	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000288	0.000849	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000286	0.000842	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000286	0.000842	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000285	0.000841	CcSEcCtD
Fluocinolone Acetonide—Oedema—Vincristine—peripheral nervous system neoplasm	0.000283	0.000835	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000282	0.000831	CcSEcCtD
Fluocinolone Acetonide—Infection—Vincristine—peripheral nervous system neoplasm	0.000281	0.000829	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000278	0.000818	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000277	0.000815	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000275	0.000811	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000275	0.000809	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000275	0.000809	CcSEcCtD
Fluocinolone Acetonide—Back pain—Etoposide—peripheral nervous system neoplasm	0.000272	0.000801	CcSEcCtD
Fluocinolone Acetonide—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000271	0.000799	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000271	0.000798	CcSEcCtD
Fluocinolone Acetonide—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000794	CcSEcCtD
Fluocinolone Acetonide—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.00079	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000268	0.00079	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000268	0.000789	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000268	0.000788	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000265	0.000782	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000265	0.000782	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000262	0.000772	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000771	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000771	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000259	0.000762	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000258	0.00076	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000257	0.000756	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000257	0.000756	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000254	0.000748	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000253	0.000744	CcSEcCtD
Fluocinolone Acetonide—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000251	0.000741	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000251	0.000738	CcSEcCtD
Fluocinolone Acetonide—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000251	0.000738	CcSEcCtD
Fluocinolone Acetonide—Infection—Cisplatin—peripheral nervous system neoplasm	0.000249	0.000733	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000249	0.000732	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000731	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000247	0.000727	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000247	0.000727	CcSEcCtD
Fluocinolone Acetonide—Rash—Topotecan—peripheral nervous system neoplasm	0.000247	0.000726	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000246	0.000726	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000246	0.000724	CcSEcCtD
Fluocinolone Acetonide—Cough—Etoposide—peripheral nervous system neoplasm	0.000245	0.000723	CcSEcCtD
Fluocinolone Acetonide—Headache—Topotecan—peripheral nervous system neoplasm	0.000245	0.000722	CcSEcCtD
Fluocinolone Acetonide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000245	0.000721	CcSEcCtD
Fluocinolone Acetonide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000245	0.000721	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000245	0.00072	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000244	0.00072	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000244	0.00072	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000243	0.000717	CcSEcCtD
Fluocinolone Acetonide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000243	0.000716	CcSEcCtD
Fluocinolone Acetonide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000243	0.000716	CcSEcCtD
Fluocinolone Acetonide—Pain—Vincristine—peripheral nervous system neoplasm	0.000242	0.000714	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000713	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000713	CcSEcCtD
Fluocinolone Acetonide—Rash—Melphalan—peripheral nervous system neoplasm	0.000241	0.000711	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000241	0.000711	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000689	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000234	0.000688	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000232	0.000685	CcSEcCtD
Fluocinolone Acetonide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000232	0.000684	CcSEcCtD
Fluocinolone Acetonide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00023	0.000679	CcSEcCtD
Fluocinolone Acetonide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00023	0.000679	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000228	0.000672	CcSEcCtD
Fluocinolone Acetonide—Infection—Etoposide—peripheral nervous system neoplasm	0.000228	0.000672	CcSEcCtD
Fluocinolone Acetonide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000227	0.00067	CcSEcCtD
Fluocinolone Acetonide—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000666	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000224	0.00066	CcSEcCtD
Fluocinolone Acetonide—Prednisolone—ABCB1—peripheral nervous system neoplasm	0.000222	0.114	CrCbGaD
Fluocinolone Acetonide—Betamethasone—ABCB1—peripheral nervous system neoplasm	0.000217	0.111	CrCbGaD
Fluocinolone Acetonide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000217	0.000639	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000217	0.000638	CcSEcCtD
Fluocinolone Acetonide—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000638	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000216	0.000637	CcSEcCtD
Fluocinolone Acetonide—Pain—Cisplatin—peripheral nervous system neoplasm	0.000214	0.000631	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000619	CcSEcCtD
Fluocinolone Acetonide—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000617	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000209	0.000615	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000208	0.000613	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000594	CcSEcCtD
Fluocinolone Acetonide—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000594	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000202	0.000594	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000201	0.000593	CcSEcCtD
Fluocinolone Acetonide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.0002	0.000589	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000198	0.000584	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000198	0.000583	CcSEcCtD
Fluocinolone Acetonide—Pain—Etoposide—peripheral nervous system neoplasm	0.000196	0.000578	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000573	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000194	0.000573	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000194	0.000571	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000557	CcSEcCtD
Fluocinolone Acetonide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000188	0.000555	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000187	0.000552	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.000551	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.00055	CcSEcCtD
Fluocinolone Acetonide—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.00055	CcSEcCtD
Fluocinolone Acetonide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000185	0.000546	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000185	0.000546	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000185	0.000544	CcSEcCtD
Fluocinolone Acetonide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000184	0.000543	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000535	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000181	0.000534	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00018	0.000531	CcSEcCtD
Fluocinolone Acetonide—Rash—Vincristine—peripheral nervous system neoplasm	0.000179	0.000526	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000178	0.000526	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000524	CcSEcCtD
Fluocinolone Acetonide—Headache—Vincristine—peripheral nervous system neoplasm	0.000178	0.000523	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000516	CcSEcCtD
Fluocinolone Acetonide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000175	0.000514	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000514	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000171	0.000505	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000498	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000169	0.000498	CcSEcCtD
Fluocinolone Acetonide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000168	0.000496	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000495	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000485	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000481	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000162	0.000478	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000476	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000471	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000159	0.000469	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000467	CcSEcCtD
Fluocinolone Acetonide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000158	0.000465	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000158	0.000465	CcSEcCtD
Fluocinolone Acetonide—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000464	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000464	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000157	0.000463	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000461	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000455	CcSEcCtD
Fluocinolone Acetonide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000449	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000152	0.000447	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000445	CcSEcCtD
Fluocinolone Acetonide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000149	0.000438	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000438	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000436	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000432	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000146	0.00043	CcSEcCtD
Fluocinolone Acetonide—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.00043	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.00043	CcSEcCtD
Fluocinolone Acetonide—Rash—Etoposide—peripheral nervous system neoplasm	0.000145	0.000426	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000145	0.000426	CcSEcCtD
Fluocinolone Acetonide—Headache—Etoposide—peripheral nervous system neoplasm	0.000144	0.000424	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000421	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000417	CcSEcCtD
Fluocinolone Acetonide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000416	CcSEcCtD
Fluocinolone Acetonide—Cough—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000405	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000405	CcSEcCtD
Fluocinolone Acetonide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000136	0.000402	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000395	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000386	CcSEcCtD
Fluocinolone Acetonide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000379	CcSEcCtD
Fluocinolone Acetonide—Infection—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000376	CcSEcCtD
Fluocinolone Acetonide—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000375	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—ABCB1—peripheral nervous system neoplasm	0.000126	0.0647	CrCbGaD
Fluocinolone Acetonide—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000372	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000366	CcSEcCtD
Fluocinolone Acetonide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000351	CcSEcCtD
Fluocinolone Acetonide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000348	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000345	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000344	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000327	CcSEcCtD
Fluocinolone Acetonide—Pain—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000324	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000319	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000303	CcSEcCtD
Fluocinolone Acetonide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.0003	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000102	0.0003	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.48e-05	0.000279	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.41e-05	0.000277	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Epirubicin—peripheral nervous system neoplasm	9.1e-05	0.000268	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.8e-05	0.000259	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.77e-05	0.000258	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.51e-05	0.000251	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000248	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.18e-05	0.000241	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.15e-05	0.00024	CcSEcCtD
Fluocinolone Acetonide—Rash—Epirubicin—peripheral nervous system neoplasm	8.11e-05	0.000239	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.1e-05	0.000239	CcSEcCtD
Fluocinolone Acetonide—Headache—Epirubicin—peripheral nervous system neoplasm	8.06e-05	0.000237	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000232	CcSEcCtD
Fluocinolone Acetonide—Nausea—Epirubicin—peripheral nervous system neoplasm	7.64e-05	0.000225	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.57e-05	0.000223	CcSEcCtD
Fluocinolone Acetonide—Rash—Doxorubicin—peripheral nervous system neoplasm	7.51e-05	0.000221	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.5e-05	0.000221	CcSEcCtD
Fluocinolone Acetonide—Headache—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.00022	CcSEcCtD
Fluocinolone Acetonide—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.07e-05	0.000208	CcSEcCtD
